Auto saved by Logseq

master
Borja Robert 11 months ago
parent 581455286b
commit 09ddb4b5a6

@ -86,4 +86,5 @@
- ### Background
- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest [[level]] of investment risk of all candidates for Combinations for [[STH]] treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation)
- El ALIVE study
- El ALIVE trial study: https://gatesopenresearch.org/articles/6-62/v1
-
Loading…
Cancel
Save